STOCKHOLDERS’ AGREEMENTStockholders’ Agreement • August 28th, 2015 • IPMD GmbH • Pharmaceutical preparations • New York
Contract Type FiledAugust 28th, 2015 Company Industry JurisdictionTHIS STOCKHOLDERS’ AGREEMENT is made as of the 31st day of January, 2014 by and among Michael Sacks (“Sacks”), The Punch Trust (“TPT”) and IPMD GmbH, an Austrian limited liability company (“IPMD” and, collectively, with Sacks and TPT, the “Investors”).
ASSIGNMENT AGREEMENTAssignment Agreement • August 28th, 2015 • IPMD GmbH • Pharmaceutical preparations • New York
Contract Type FiledAugust 28th, 2015 Company Industry JurisdictionThis Assignment Agreement (this “Agreement”) is made as of January 31, 2014 (the “Effective Date”) by and among Michael Sacks (“Sacks”), The Punch Trust (“TPT” and together with Sacks, the “Assignees”), and IPMD GmbH, an Austrian limited liability company (the “Assignor”). The Assignor and the Assignees are referred to collectively in this agreement as the “parties.”
EQUALIZATION AGREEMENTEqualization Agreement • August 28th, 2015 • IPMD GmbH • Pharmaceutical preparations • New York
Contract Type FiledAugust 28th, 2015 Company Industry JurisdictionTHIS EQUALIZATION AGREEMENT (this “Agreement”) is made as of the 31st day of January, 2014 by and among Michael Sacks (“Sacks”), The Punch Trust (“TPT” and, together with Sacks, the “Investors”), Melmed Holdings AG, a company incorporated in Switzerland (“Melmed”), and IPMD GmbH, an Austrian limited liability company (“IPMD”). The Investors, Melmed and IPMD are referred to collectively in this Agreement as the “parties.”
AMENDMENT TO STOCKHOLDERS’ AGREEMENTStockholders’ Agreement • August 28th, 2015 • IPMD GmbH • Pharmaceutical preparations • New York
Contract Type FiledAugust 28th, 2015 Company Industry JurisdictionTHIS AMENDMENT TO STOCKHOLDERS’ AGREEMENT (this “Amendment”) is made as of July 27, 2015 by and among Michael Sacks (“Sacks”), The Punch Trust (“TPT”) and IPMD GmbH, an Austrian limited liability company (“IPMD” and, collectively, with Sacks and TPT, the “Investors”).